Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.

The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News.

Leave a Replay

Sign up for our Newsletter

Contact Us